284 related articles for article (PubMed ID: 15792678)
21. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
[TBL] [Abstract][Full Text] [Related]
23. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
24. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
Amiral J
Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
Chong BH; Eisbacher M
Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
[TBL] [Abstract][Full Text] [Related]
26. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
[TBL] [Abstract][Full Text] [Related]
28. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
[TBL] [Abstract][Full Text] [Related]
29. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
Fretschner R; Dietrich K; Unertl K; Greinacher A
Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
[TBL] [Abstract][Full Text] [Related]
30. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization.
Gluckman TJ; Segal JB; Fredde NL; Saland KE; Jani JT; Walenga JM; Prechel MM; Citro KM; Zidar DA; Fox E; Schulman SP; Kickler TS; Rade JJ
Am J Cardiol; 2005 Mar; 95(6):744-7. PubMed ID: 15757601
[TBL] [Abstract][Full Text] [Related]
31. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia.
Zucker MJ; Sabnani I; Baran DA; Balasubramanian S; Camacho M
J Heart Lung Transplant; 2010 Jan; 29(1):53-60. PubMed ID: 19819167
[TBL] [Abstract][Full Text] [Related]
32. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
33. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
34. Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes.
Mascelli MA; Deliargyris EN; Damaraju LV; Barnathan ES; Sane DC
Semin Thromb Hemost; 2004 Jun; 30(3):347-50. PubMed ID: 15282657
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of recurrent angina after acute coronary syndrome: the global registry acute coronary events from China (Sino-GRACE).
Zhao FH; Chen YD; Song XT; Pan WQ; Jin ZN; Yuan F; Li YB; Ren F; Lü SZ;
Chin Med J (Engl); 2008 Jan; 121(1):12-6. PubMed ID: 18208658
[TBL] [Abstract][Full Text] [Related]
36. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
37. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
39. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
[TBL] [Abstract][Full Text] [Related]
40. Heparin-induced thrombocytopenia, a prothrombotic disease.
Levy JH; Hursting MJ
Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]